Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Brooklyn ImmunoTherapeutics, Inc. | Chief Financial Officer | Stock Option (right to buy) | 665K | Jun 3, 2022 | Direct | ||
Calidi Biotherapeutics, Inc. | Chief Financial Officer | Stock Options (right to buy) | 300K | Jun 17, 2024 | Direct | ||
Ra Medical Systems, Inc. | CFO | Common Stock | 21.7K | May 20, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CLDI | Calidi Biotherapeutics, Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Chief Financial Officer |
CLDI | Calidi Biotherapeutics, Inc. | Oct 30, 2023 | 0 | $0 | 3 | Nov 2, 2023 | Chief Financial Officer |
ERNA | Brooklyn ImmunoTherapeutics, Inc. | Jun 3, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Chief Financial Officer |
ERNA | Brooklyn ImmunoTherapeutics, Inc. | May 31, 2022 | 0 | $0 | 3 | Jun 1, 2022 | Chief Financial Officer |
RMED | Ra Medical Systems, Inc. | May 20, 2022 | 1 | -$410 | 4 | May 24, 2022 | CFO |
RMED | Ra Medical Systems, Inc. | Nov 20, 2021 | 2 | -$7.03K | 4 | Nov 24, 2021 | CFO |